Compare MYGN & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | CBAN |
|---|---|---|
| Founded | 1991 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 436.3M |
| IPO Year | 1996 | 1995 |
| Metric | MYGN | CBAN |
|---|---|---|
| Price | $4.89 | $20.97 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.64 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 232.3K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ 16.91 |
| EPS | N/A | ★ 1.59 |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.89 | $35.41 |
| Revenue Next Year | $5.35 | $4.84 |
| P/E Ratio | ★ N/A | $13.17 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $14.54 |
| 52 Week High | $8.59 | $21.46 |
| Indicator | MYGN | CBAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 68.22 |
| Support Level | $4.23 | $15.96 |
| Resistance Level | $5.67 | $21.04 |
| Average True Range (ATR) | 0.27 | 0.38 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 87.97 | 82.41 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.